1
van der Lee, Arnold P. M., Önsesveren, Ibrahim, Wierdsma, André I., van Westrhenen, Roos, Beekman, Aartjan T. F., de Haan, Lieuwe, Mulder, Niels C. L.
Veröffentlicht in: van der Lee , A P M , Önsesveren , I , Wierdsma , A I , van Westrhenen , R , Beekman , A T F , de Haan , L & Mulder , N C L 2021 , ' The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia: A Dutch Registry-Based Retrospective Cohort Study ' , CNS Drugs , vol. 35 , no. 4 , pp. 451-460 . https://doi.org/10.1007/s40263-021-00802-3;
2021
Veröffentlicht in: van der Lee , A P M , Önsesveren , I , Wierdsma , A I , van Westrhenen , R , Beekman , A T F , de Haan , L & Mulder , N C L 2021 , ' The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia: A Dutch Registry-Based Retrospective Cohort Study ' , CNS Drugs , vol. 35 , no. 4 , pp. 451-460 . https://doi.org/10.1007/s40263-021-00802-3;
2021
2
van der Lee, Arnold P.M., Önsesveren, Ibrahim, Wierdsma, André I., van Westrhenen, Roos, Beekman, Aartjan T.F., de Haan, Lieuwe, Mulder, Niels C.L.
Veröffentlicht in: van der Lee , A P M , Önsesveren , I , Wierdsma , A I , van Westrhenen , R , Beekman , A T F , de Haan , L & Mulder , N C L 2021 , ' The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia : A Dutch Registry-Based Retrospective Cohort Study ' , CNS Drugs , vol. 35 , no. 4 , pp. 451-460 . https://doi.org/10.1007/s40263-021-00802-3;
2021
Veröffentlicht in: van der Lee , A P M , Önsesveren , I , Wierdsma , A I , van Westrhenen , R , Beekman , A T F , de Haan , L & Mulder , N C L 2021 , ' The Impact of Antipsychotic Formulations on Time to Medication Discontinuation in Patients with Schizophrenia : A Dutch Registry-Based Retrospective Cohort Study ' , CNS Drugs , vol. 35 , no. 4 , pp. 451-460 . https://doi.org/10.1007/s40263-021-00802-3;
2021